Skip to main content
Caplight Logo









KCell Biosciences

KCell Biosciences

Private
BusanHealthcare & Life Scienceshttps://k-cell.com/

Last Round

Corporate Funding

Mar 7, 2025

Total Funding Raised

$8.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

KCell Biosciences is a biotechnology company that manufactures serum-free and chemically defined cell culture media for biopharmaceutical and cultivated food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

cell culture mediaCDMOcontract development and manufacturing organizationserum-free mediachemically defined mediacell line developmentbioprocess developmentcultivated meatlab-grown meatbiopharma manufacturingtransient transfectionmedia optimizationbasal mediabiotech supply chaincellular agriculture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KCell Biosciences Comparables

Compare KCell Biosciences with similar companies based on industry and business-model similarity.

KCell Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Welgene Inc.
83%
Defined Bioscience
81%
Thousand Oaks Biopharmaceuticals
75%

KCell Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMar 7, 2025
Series AJul 12, 2022

Key People

Founding team and executive leadership

Victor Kang

Chief Executive Officer

Executive Team

Kwon hee Lee

경영관리(CFO)

Executive Team

KCell Biosciences Investors

Notable investors and investment history

KCell Biosciences investors
InvestorRounds
CKD Venture CapitalSeries A
DAYLI PartnersSeries A
Sema InvestmentSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 81% MoM.

  • Dec 9, 2025

    Monthly visitors increased 32% MoM.

KCell Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KCell Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KCell Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBusan
Employee Range6
Year Founded2021
Last FundingMar 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?